ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI FY 1986 Bypass Budget Asks 41.445 Billion with Major Increase Tied To Goal for Year 2000

May 18, 1984

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

DCT Board Approves Drug Development Recompetition

November 30, 1990

Missouri, Michigan Program As For Comprehensive Review

September 23, 1977

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975